Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing P3HT/PCBM-Based Organic Photodetector Performance: Insights from SCAPS 1D Simulation Studies.

Nanomaterials (Basel, Switzerland)·2024
Same author

Refractive Index Formula of Blood as a Function of Temperature and Concentration.

Anais da Academia Brasileira de Ciencias·2021
Same author

GaInNAs-based Hellish-vertical cavity semiconductor optical amplifier for 1.3 μm operation.

Nanoscale research letters·2011
See all related articles

Related Experiment Video

Updated: Jul 26, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.7K

Hybrid classical and quantum computing for enhanced glioma tumor classification using TCGA data.

Emine Akpinar1, Murat Oduncuoglu2

  • 1Department of Physics, Yildiz Technical University, Istanbul, Turkey. emineakpinar28@gmail.com.

Scientific Reports
|July 17, 2025
PubMed
Summary

This study introduces a hybrid quantum-classical AI model for classifying low-grade gliomas (LGGs) from high-grade gliomas (HGGs). The novel approach achieved 74% accuracy, identifying key molecular and clinical features for improved brain tumor diagnosis.

Keywords:
Ensemble feature selectionGliomaHybrid classical and quantum computingMolecular markersVariational quantum classifier

More Related Videos

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.0K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K

Related Experiment Videos

Last Updated: Jul 26, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.7K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.0K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K

Area of Science:

  • Neuro-oncology
  • Quantum Computing
  • Artificial Intelligence

Background:

  • Gliomas, the most common primary brain tumors, pose diagnostic challenges due to significant differences in survival and treatment response between low-grade (LGGs) and high-grade (HGGs) subtypes.
  • Accurate classification of gliomas is critical for determining appropriate treatment strategies and predicting patient prognosis.
  • Classical AI methods face limitations with large, noisy medical datasets and complex data structures, hindering optimal glioma classification.

Purpose of the Study:

  • To develop and evaluate a novel hybrid classical and quantum computing model for distinguishing between LGGs and HGGs.
  • To leverage quantum computing's potential for enhanced data processing and analysis in medical diagnostics.
  • To identify key molecular and clinical features that differentiate LGG from HGG using a hybrid approach.

Main Methods:

  • A hybrid model combining classical ensemble feature selection with variational quantum classifiers (VQCs) was developed using The Cancer Genome Atlas (TCGA) data.
  • An ensemble method identified informative molecular and clinical features from the TCGA dataset.
  • Six VQC models with different hyperparameters were trained and evaluated for their ability to classify LGGs from HGGs, with the AQCD optimization method used.

Main Results:

  • The VQC-1 model, utilizing specific quantum gates and the AQCD optimization, achieved the highest classification accuracy of 0.74.
  • The most important features identified by VQC-1 for distinguishing LGGs from HGGs were IDH1, age at diagnosis, PTEN, EGFR, and ATRX.
  • In five-fold cross-validation, VQC-1 performance was comparable to XGBoost and GBM, outperforming KNN, SVC, DTC, and RFC.

Conclusions:

  • Hybrid classical and quantum computing models offer a promising approach for complex medical classification tasks like glioma grading.
  • The developed VQC-1 model demonstrates the potential of quantum AI in improving the accuracy and efficiency of brain tumor classification.
  • This study highlights the significance of integrating quantum computational methods with classical machine learning for advancing neuro-oncology diagnostics.